These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 8885625)

  • 21. [Triggered arrhythmias using the monophasic action potential technique].
    Xie JT; Xie LH
    Sheng Li Ke Xue Jin Zhan; 1990 Oct; 21(4):363-6. PubMed ID: 2100892
    [No Abstract]   [Full Text] [Related]  

  • 22. The management of ventricular dysrhythmia in aconite poisoning.
    Coulson JM; Caparrotta TM; Thompson JP
    Clin Toxicol (Phila); 2017 Jun; 55(5):313-321. PubMed ID: 28421842
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel insights into the role of the sympathetic nervous system in cardiac arrhythmogenesis.
    Volders PG
    Heart Rhythm; 2010 Dec; 7(12):1900-6. PubMed ID: 20570754
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Electrophysiological study of the arrhythmogenic effects of digoxin in ventricular myocardial fragments of guinea pigs stimulated at low frequency. Inhibitory action of caffeine].
    Adamantidis MM; Duriez PR; Rouet RH; Dupuis BA
    J Pharmacol; 1984; 15(3):287-300. PubMed ID: 6492818
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of the nervous system in experimentally induced arrhythmias.
    Gillis RA; Corr PB; Pace DG; Evans DE; DiMicco J; Pearle DL
    Cardiology; 1976; 61(1):37-49. PubMed ID: 975123
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Azithromycin Causes a Novel Proarrhythmic Syndrome.
    Yang Z; Prinsen JK; Bersell KR; Shen W; Yermalitskaya L; Sidorova T; Luis PB; Hall L; Zhang W; Du L; Milne G; Tucker P; George AL; Campbell CM; Pickett RA; Shaffer CM; Chopra N; Yang T; Knollmann BC; Roden DM; Murray KT
    Circ Arrhythm Electrophysiol; 2017 Apr; 10(4):. PubMed ID: 28408648
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential effects of antiarrhythmic agents on post-pause repolarization in cardiac Purkinje fibres.
    Wyse KR; Bursill JA; Campbell TJ
    Clin Exp Pharmacol Physiol; 1996 Sep; 23(9):825-9. PubMed ID: 8911721
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sympatho-adrenergic activation of the ischemic myocardium and its arrhythmogenic impact.
    Schömig A; Richardt G; Kurz T
    Herz; 1995 Jun; 20(3):169-86. PubMed ID: 7635399
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ATP promotes development of afterdepolarizations and triggered activity in cardiac myocytes.
    Song Y; Belardinelli L
    Am J Physiol; 1994 Nov; 267(5 Pt 2):H2005-11. PubMed ID: 7526716
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Ion channels and arrhythmias].
    Borchard U; Hafner D
    Z Kardiol; 2000; 89 Suppl 3():6-12. PubMed ID: 10810780
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Proarrhythmic response to potassium channel blockade. Numerical studies of polymorphic tachyarrhythmias.
    Starmer CF; Romashko DN; Reddy RS; Zilberter YI; Starobin J; Grant AO; Krinsky VI
    Circulation; 1995 Aug; 92(3):595-605. PubMed ID: 7634474
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pro-arrhythmic effects of low plasma [K
    Trenor B; Cardona K; Romero L; Gomez JF; Saiz J; Rajamani S; Belardinelli L; Giles W
    Trends Cardiovasc Med; 2018 May; 28(4):233-242. PubMed ID: 29203397
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A multiscale computational modelling approach predicts mechanisms of female sex risk in the setting of arousal-induced arrhythmias.
    Yang PC; Perissinotti LL; López-Redondo F; Wang Y; DeMarco KR; Jeng MT; Vorobyov I; Harvey RD; Kurokawa J; Noskov SY; Clancy CE
    J Physiol; 2017 Jul; 595(14):4695-4723. PubMed ID: 28516454
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Contrastive effects of prostaglandin F2 alpha on normal cardiac rhythm and ouabain-induced cardiac arrhythmias in cats: possible neural basis.
    Rao TS; Seth SD; Manchanda SC; Nayar U
    Arch Int Pharmacodyn Ther; 1989; 302():128-44. PubMed ID: 2636814
    [TBL] [Abstract][Full Text] [Related]  

  • 35. I(Ks) blockade in border zone arrhythmias from guinea-pig ventricular myocardium submitted to simulated ischemia and reperfusion.
    Puddu PE; Sallé L; Gérard JL; Rouet R; Ducroq J
    Fundam Clin Pharmacol; 2012 Aug; 26(4):445-53. PubMed ID: 21781157
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of some components of ischemia in the genesis of spontaneous ventricular arrhythmias.
    Senges J; Seller H; Brachmann J; Braun W; Mayer E; Rizos I; Kübler W
    Basic Res Cardiol; 1984; 79(1):68-74. PubMed ID: 6610414
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ischemic modulation of vulnerable period and the effects of pharmacological treatment of ischemia-induced arrhythmias: a simulation study.
    Cimponeriu A; Starmer CF; Bezerianos A
    IEEE Trans Biomed Eng; 2003 Feb; 50(2):168-77. PubMed ID: 12665030
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Membrane factors in arrhythmogenesis: concepts and definitions.
    Arnsdorf MF
    Prog Cardiovasc Dis; 1977; 19(6):413-29. PubMed ID: 193148
    [No Abstract]   [Full Text] [Related]  

  • 39. Potassium channel blockade amplifies cardiac instability numerical studies of torsades de pointes.
    Starmer CF; Reddy MR; Namasivayam A; Singh M
    Indian J Physiol Pharmacol; 1994 Oct; 38(4):259-66. PubMed ID: 7883289
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Specific potassium channel blockade for arrhythmia prevention in the ionically remodeled failing heart: peril or panacea?
    Nattel S
    Heart Rhythm; 2005 Jul; 2(7):739-40. PubMed ID: 15992731
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.